MPG.eBooks - Search Results

1

Clinical and economic review report: Infliximab SC (Remsima) : Celltrion Healthcare Co., Ltd. : indication : rheumatoid arthritis

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...Clinical and economic review report for infliximab (Remsima)...”

Read Now

2

Axicabtagene ciloleucel for diffuse large B-cell lymphoma: Economic review report

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antigens, CD19 / economics...”

Read Now

3

Axicabtagene ciloleucel for diffuse large B-cell lymphoma: Economic review report

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Economic review report...”

Read Now

4

Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review Clinical and economic review report for Vedolizumab (Entyvio SC)...”

Read Now

5

Direct oral anticoagulants for the treatment of venous thromboembolic events : economic evaluation

by Klarenbach, Scott
Published 2016

CADTH

Subjects: “...Anticoagulants / economics...”

Read Now

6

Vancomycin or metronidazole for treatment of Clostridium difficile infection : clinical and economic analyses

by Perras, Christine
Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Vancomycin / economics...”

Read Now

7

Direct oral anticoagulants for the treatment of venous thromboembolic events : economic evaluation

by Klarenbach, Scott
Published 2016

CADTH

“... includes both a clinical and an economic evaluation. The clinical component was conducted by ccNMA...”

Read Now

8

Vancomycin or metronidazole for treatment of Clostridium difficile infection : clinical and economic analyses

by Perras, Christine
Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Vancomycin / economics...”

Read Now

9

Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies

Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Warfarin / economics...”

Read Now

10

Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies

Published 2011

Canadian Agency for Drugs and Technologies in Health

Read Now

11

Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : systematic review and economic analysis

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Monitoring / economics...”

Read Now

12

Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : systematic review and economic analysis

Published 2014

Canadian Agency for Drugs and Technologies in Health

“... the accuracy and clinical effectiveness of POC INR. We also performed a primary economic analysis of the cost...”

Read Now

13

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Therapy, Combination / economics...”

Read Now

14

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Therapy, Combination / economics...”

Read Now

15

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Therapy, Combination / economics...”

Read Now

16

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration

by Wells, George A.
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Therapy, Combination / economics...”

Read Now

17

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Clinical and economic impact of standard versus extended duration...”

Read Now

18

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration

by Wells, George A.
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Clinical and economic impact of standard versus extended duration...”

Read Now

19

Robot-assisted surgery compared with open surgery and laparoscopic surgery : clinical effectiveness and economic analyses

by Ho, Chuong
Published 2011

Canadian Agency for Drugs and Technologies in Health

“... procedures and laparoscopic procedures, followed by a systematic review of economic evaluation studies. We...”

Read Now

20

Robot-assisted surgery compared with open surgery and laparoscopic surgery : clinical effectiveness and economic analyses

by Ho, Chuong
Published 2011

Canadian Agency for Drugs and Technologies in Health

“... procedures and laparoscopic procedures, followed by a systematic review of economic evaluation studies. We...”

Narrow Search